Invest in InsituGen
With the world’s first low-cost test for the detection of androgen and estrogen bioactivity, InsituGen is developing cell-free bioassay technology to reinvent steroid hormone testing in companion animal diagnostic.
InsituGen are currently seeking investment to support the next phase of growth, including product development, commercial expansion, and strategic partnerships.
Our Story
Founded in 2020, InsituGen was created from Professor Alison Heather’s work on steroid hormone bioassay development. Since then, InsituGen has launched products in equine anti-doping (firstFlagX) and companion animal diagnostics (NeuterReady), and provided product testing to a number of companies at the forefront of human performance and health. InsituGen’s team brings experience across biotechnology, animal health, and commercialization.
InsituGen are currently raising investment to accelerate:
- Future product development in companion animal health
- Market expansion and strategic collaborations
- Further develop our products towards a clear point-of-care pathway
The Opportunity Ahead
Demand for faster and more accessible bioassay solutions will continue to grow across environmental, animal and human health, diagnostics, and biotechnology sectors. InsituGen is positioned to capitalise on this opportunity through our bioassay technology platform, a clear commercialization pathway, and a scalable business model.